NCICancer

Recently, @michyong.bsky.social presented at the 9th Annual #ICBMT2025 in Busan, Korea on CMV Infection in Allogeneic HSCT: Risk Stratification and Prevention, focused on advances in prophylaxis for CMV management after allogeneic hematopoietic stem cell transplantation- Congratulations!

he NCIC September newsletter is out! 📢

Read all about our research updates, recent publications and upcoming events: cancerandinfections.org/newsletter

Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group.

Read the full article here: bmjopen.bmj.com/content/15/7...

The INTERACT study: Infection prevention and surveillance practice in the care of the Australasian cancer and transplant population Australasian cancer and transplant populations are expanding, with increased infection risk related to prolonged survivorship and broader use of novel immunosuppressants. To optimise care, standardise...

Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky

www.ajicjournal.org/article/S019...

You're invited to the NCIC Showcase!

Learn about our work in infection & cancer care through rapid 2-min talks from clinicians, scientists & more.

📅 7 Aug | 🕧 12:30–2PM | 🏢 PMCC & Teams

🍽️ Lunch/tea included

Register here: cancerandinfections.org/ncic-showcase

Join us for the Asia Fungal Working Group and ASID's ANZMIG Fungal Frontier Asia Pacific webinar on Emerging Dermatophyte Infections: Arrival of Antifungal Drug Resistance.

📅 Date: 3rd of September
⌚ Time: 19.30 AEST
📍 Location: Online

👉 Register here: asidevents.eventsair.com/anzmig-2025-...

📰 July Newsletter is Out Now!

Catch up on the latest updates, research highlights, and upcoming events.

📖 Read it here: cancerandinfections.org/newsletter

2 WEEKS AWAY

Join us for this hybrid event on Friday July 25th in Melbourne where we will hear updates in candida and other yeast clinical and laboratory diagnosis and management, as well the "ins and outs" of the Australasia Candidaemia Study III.

Register: cancerandinfections.org/acsiii-regis...

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial In an in-depth immunological analysis of alternate influenza vaccination strategies in high-risk patients receiving therapy for hematological malignancy, p

Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...

Sign up today on our website: cancerandinfections.org

We were proud to be well represented at the inaugural The
Transplantation Society of Australia and New Zealand Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with ASID Immunocompromised Host Special Interest Group.

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study Only a small number of antifungal therapies for invasive fungal disease (IFD) are currently available, and many pathogens are resistant to one or more…

Read here: www.sciencedirect.com/science/arti...

New Publication!
Professor Monica Slavin - “Very pleased to be part of this important study of olorofim, a novel antifungal drug for difficult-to-treat fungal infections. It was active against infections resistant to or failing existing treatments and offers a much-needed option for our patients.”

Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky

Today, Belinda Lambros, presented on the Nursing Considerations from the Australasian Consensus Guidelines for Neutropenic Fever 2024 update at the 2025 Cancer Nurses Society Of Australia (CNSA) and International Society of Nurses in Cancer Care ISNCC congress.

Happy Friday!

The June edition of the NCIC Newsletter is now live.

To read, please visit: cancerandinfections.org/newsletter

We're Hiring!

2026 Peter MacCallum Cancer Centre ID Registrar

This is a fully accredited advanced trainee position for an ID physician looking for further training in the Immunocompromised Host, based at the Peter MacCallum Cancer Centre.

Learn more: careers.petermac.org/job/MELBOURN...

This week, we said farewell to Enric, our visiting research fellow from Spain, who spent the past three months with us. We wish him all the best in his future endeavors!
Learn more about our visiting fellow program: cancerandinfections.org/visiting-fel...

Join us next Wednesday for the Asia Fungal Working Group and the Australia & New Zealand Mycology Interest Group (ANZMIG) webinar.

Dr Abby Douglas is an invited expert panelist!

Wednesday, May 28
7:00 PM – 8:30 PM AEST
Fungus in a Joint – Osteoarticular Infections

Register here: bit.ly/FFAP2025

Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social

We are proud to share that the amazing Antibiotic Allergy Nursing Team has been nominated for the @petermaccc.bsky.social Annual Nursing Awards in celebration of International Nurses Day. Well done team!

Day 2 of the @petermaccc.bsky.social Research Symposium opened with A/Prof @michyong.bsky.social plenary on "Transforming the care of Infectious Diseases in Cancer Patients." Discussing groundbreaking research and future directions in fungal, viral, bacterial, and vaccine clinical trials.

Happy Friday!

The latest NCIC Newsletter is out now. Catch up on key updates and news.

Check it out here: cancerandinfections.org/newsletter

NCIC Fellow A/Prof Michelle Yong giving us all a great lesson in the complexities of viral infection post transplant #escmidglobal

Another head scratcher case for Monica and Dimitrios #escmidglobal

Prof Slavin discussing a very unusual case #escmidglobal Clinical grand rounds

NCIC fellow Dr Abby Douglas and next gen sequencing have found many ICH pts have previously undetected viruses (incl pegiviruses) that are associated with worse outcomes. Markers of overall immunosuppression or causative??#escmidglobal

NCIC Dr Zoe Neoh presenting results of the NAM study- 21 centres, 420 cases, emergence of non aspergillosis moulds #escmidglobal

NCIC visiting fellow alum Dr Julien Coussement presenting results of his ANZ crypto study- higher risk of IRIS. #escmidglobal

#escmidglobal